Awarded contract

NHS Framework Agreement for the Supply of Direct Oral Anticoagulant (DOAC) Medicines for the NHS in England

Details

Buyer: NHS England
Supplier(s): Bristol-Myers Squibb Pharmaceuticals Ltd, Bayer Ltd, Daiichi Sankyo UK Ltd
Value: GBP 3,185,000,000
Topic: Pharmaceutical products
Published: 25 November 2021
Source: uk:find_a_tender

Tender description

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs).Period of Framework: 01/01/2022 - 31/04/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 39 months) Lot 1: NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs).Period of Framework: 01/01/2022 - 31/04/2024 with an option to extend (at the Authority’s discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 39 months)

Timeline

Completed: Award date15 November 2021
Completed: Award published25 November 2021
Current notice

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products
33690000 · Various medicinal products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@nhs-england.gov
Commercial Director	+44 •••• ••••••	••••••••@nhs-england.gov
Procurement Manager	+44 •••• ••••••	••••••••@nhs-england.gov
Category Lead	+44 •••• ••••••	••••••••@nhs-england.gov
Senior Buyer	+44 •••• ••••••	••••••••@nhs-england.gov
Contracts Manager	+44 •••• ••••••	••••••••@nhs-england.gov